Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Dexamethasone + VLX1570 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Dexamethasone | Adexone | Desametasone | ||
| VLX1570 | VLX1570 is a small-molecule that inhibits USP14 and UCHL5, which may result in increased tumor cell death (PMID: 27813535, PMID: 32635430, PMID: 32125598). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02372240 | Phase Ib/II | Dexamethasone + VLX1570 | A Study of VLX1570 and Dexamethasone in Myeloma Patients | Terminated | USA | 0 |